The fill-finish market—a traditionally stable one—is increasingly adopting new technologies. Research from our 12th Annual Report and Survey of Biopharmaceutical Manufacturing, and other studies ...

Dublin, Jan. 05, 2026 (GLOBE NEWSWIRE) -- The "Fill Finish Manufacturing Market - A Global and Regional Analysis: Focus on Product, End Users, and Region - Analysis and Forecast, 2025-2035" has been ...

SPOKANE, Wash.--(BUSINESS WIRE)--Selkirk Pharma, Inc., a privately held U.S. pharmaceutical manufacturer specializing in the fill and finish of injectable drugs, including vaccines and biological ...

Growth of the biopharmaceutical industry. Rising technological advancements in fill-finish manufacturing processes. Rising adoption of prefilled syringes for parenteral dosage forms. The study ...

Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "Fill Finish Manufacturing Market by Product ((Consumables (PFS (Glass), Plunger Stopper), Vial (RTU, Polymer), Vial ...

A booming biologics market is increasing demand for specialist fill-finish services and prompting contractors to invest in technologies that reduce waste and safeguard these sensitive medicines. The ...

PCI Pharma, a Philadelphia-based CDMO, will spend $100 million to beef up aseptic liquid fill-finish manufacturing operations at its Bedford, New Hampshire, facility. The project follows PCI’s ...

The "Fill Finish Pharmaceutical Contract Manufacturing Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Fill Finish Service Offered, Type of FDF, API Potency, Type of ...

-New service ensures rapid delivery of small volume clinical trial materials, solving a critical bottleneck in drug development- SPOKANE, Wash.–(BUSINESS WIRE)–February 12, 2025– Selkirk Pharma, Inc., ...